Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
BackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/full |
id |
doaj-27a84ec0b70242688c13eb621805645e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joyce de Cassia Rosa de Jesus Ariene Soares de Pinho Murari Katrin Radloff Ruan Carlos Macêdo de Moraes Raquel Galvão Figuerêdo Ana Flavia Marçal Pessoa José César Rosa-Neto Emídio Marques Matos-Neto Paulo S. M. Alcântara Flavio Tokeshi Linda Ferreira Maximiano Fang Chia Bin Fernanda Bellotti Formiga José P. Otoch José P. Otoch Marilia Seelaender |
spellingShingle |
Joyce de Cassia Rosa de Jesus Ariene Soares de Pinho Murari Katrin Radloff Ruan Carlos Macêdo de Moraes Raquel Galvão Figuerêdo Ana Flavia Marçal Pessoa José César Rosa-Neto Emídio Marques Matos-Neto Paulo S. M. Alcântara Flavio Tokeshi Linda Ferreira Maximiano Fang Chia Bin Fernanda Bellotti Formiga José P. Otoch José P. Otoch Marilia Seelaender Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia Frontiers in Immunology neoplasms cachexia adipose tissue heterogeneity inflammation NLRP3 inflammasome |
author_facet |
Joyce de Cassia Rosa de Jesus Ariene Soares de Pinho Murari Katrin Radloff Ruan Carlos Macêdo de Moraes Raquel Galvão Figuerêdo Ana Flavia Marçal Pessoa José César Rosa-Neto Emídio Marques Matos-Neto Paulo S. M. Alcântara Flavio Tokeshi Linda Ferreira Maximiano Fang Chia Bin Fernanda Bellotti Formiga José P. Otoch José P. Otoch Marilia Seelaender |
author_sort |
Joyce de Cassia Rosa de Jesus |
title |
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia |
title_short |
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia |
title_full |
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia |
title_fullStr |
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia |
title_full_unstemmed |
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia |
title_sort |
activation of the adipose tissue nlrp3 inflammasome pathway in cancer cachexia |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-09-01 |
description |
BackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors which drive the systemic inflammation, a hallmark of the syndrome. While inflammation is a defensive innate response, the control mechanisms have been reported to be disrupted in cachexia. On the other hand, little is known about the role of NLRP3 inflammasome in this scenario, a multiprotein complex involved in caspase-1 activation and the processing of the cytokines IL-1β and IL-18.Aimbased on the evidence from our previous study with a rodent model of cachexia, we examined the activation of the NLRP3 inflammasome pathway in two adipose tissue depots obtained from patients with colorectal cancer and compared with that another inflammatory pathway, NF-κB.ResultsFor CC we found opposite modulation in ScAT and PtAT for the gene expression of TLR4, Caspase-1 (cachectic group) and for NF-κB p50, NF-κB p65, IL-1β. CD36, expression was decreased in both depots while that of NLRP3 and IL-18 was higher in both tissues, as compared with controls and weight stable patients (WSC). Caspase-1 basal protein levels in the ScAT culture supernatant were higher in WSC and (weight stable patients) CC, when compared to controls. Basal ScAT explant culture medium IL-1β and IL-18 protein content in ScAT supernatant was decreased in the WSC and CC as compared to CTL explants.ConclusionsThe results demonstrate heterogeneous responses in the activation of genes of the NLRP3 inflammasome pathway in the adipose tissue of patients with cancer cachexia, rendering this pathway a potential target for therapy aiming at decreasing chronic inflammation in cancer. |
topic |
neoplasms cachexia adipose tissue heterogeneity inflammation NLRP3 inflammasome |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/full |
work_keys_str_mv |
AT joycedecassiarosadejesus activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT arienesoaresdepinhomurari activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT katrinradloff activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT ruancarlosmacedodemoraes activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT raquelgalvaofigueredo activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT anaflaviamarcalpessoa activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT josecesarrosaneto activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT emidiomarquesmatosneto activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT paulosmalcantara activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT flaviotokeshi activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT lindaferreiramaximiano activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT fangchiabin activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT fernandabellottiformiga activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT josepotoch activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT josepotoch activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia AT mariliaseelaender activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia |
_version_ |
1717370589792960512 |
spelling |
doaj-27a84ec0b70242688c13eb621805645e2021-09-23T05:56:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.729182729182Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer CachexiaJoyce de Cassia Rosa de Jesus0Ariene Soares de Pinho Murari1Katrin Radloff2Ruan Carlos Macêdo de Moraes3Raquel Galvão Figuerêdo4Ana Flavia Marçal Pessoa5José César Rosa-Neto6Emídio Marques Matos-Neto7Paulo S. M. Alcântara8Flavio Tokeshi9Linda Ferreira Maximiano10Fang Chia Bin11Fernanda Bellotti Formiga12José P. Otoch13José P. Otoch14Marilia Seelaender15Cancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilImmunometabolism Laboratory, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilDepartment of Coloproctology, Santa Casa de São Paulo, São Paulo, BrazilDepartment of Coloproctology, Santa Casa de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilBackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors which drive the systemic inflammation, a hallmark of the syndrome. While inflammation is a defensive innate response, the control mechanisms have been reported to be disrupted in cachexia. On the other hand, little is known about the role of NLRP3 inflammasome in this scenario, a multiprotein complex involved in caspase-1 activation and the processing of the cytokines IL-1β and IL-18.Aimbased on the evidence from our previous study with a rodent model of cachexia, we examined the activation of the NLRP3 inflammasome pathway in two adipose tissue depots obtained from patients with colorectal cancer and compared with that another inflammatory pathway, NF-κB.ResultsFor CC we found opposite modulation in ScAT and PtAT for the gene expression of TLR4, Caspase-1 (cachectic group) and for NF-κB p50, NF-κB p65, IL-1β. CD36, expression was decreased in both depots while that of NLRP3 and IL-18 was higher in both tissues, as compared with controls and weight stable patients (WSC). Caspase-1 basal protein levels in the ScAT culture supernatant were higher in WSC and (weight stable patients) CC, when compared to controls. Basal ScAT explant culture medium IL-1β and IL-18 protein content in ScAT supernatant was decreased in the WSC and CC as compared to CTL explants.ConclusionsThe results demonstrate heterogeneous responses in the activation of genes of the NLRP3 inflammasome pathway in the adipose tissue of patients with cancer cachexia, rendering this pathway a potential target for therapy aiming at decreasing chronic inflammation in cancer.https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/fullneoplasmscachexiaadipose tissue heterogeneityinflammationNLRP3 inflammasome |